Skip to main content

What type of drug is Vitrakvi (larotrectinib)?

Medically reviewed by Drugs.com. Last updated on Nov 22, 2024.

Official Answer by Drugs.com

Vitrakvi is an inhibitor of the tropomyosin receptor kinases, TRKA, TRKB, and TRKC. Vitrakvi is used to treat adults and children with solid tumors.

In November 2018 the U.S. Food and Drug Administration (FDA) approved Vitrakvi (larotrectinib), an oral treatment for adults and children with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion. Vitrakvi is the first TRK inhibitor for cancers that express this mutation.

Read next

What is the strongest chemotherapy drug for breast cancer?

Doxorubicin is considered one of the strongest chemotherapy drugs for breast cancer ever invented. It can kill cancer cells at every point in their life cycle, and it's used to treat a wide variety of cancers, not just breast cancer. Doxorubicin is also known as “The Red Devil” because it is a clear bright red color. It can cause your urine or other body fluids to turn a reddish color for 1 to 2 days after a dose is given, which is normal and temporary. Continue reading

Which medications make you sleepy?

Many medications can make you sleepy – some intentionally – such as sleeping pills, but others can make you tired as a side effect or an unintended consequence of the medication. It is important to know before taking a medication if there is a chance it may make you sleepy, drowsy, tired, or fatigued, because this may have an impact on your driving or ability to operate machinery, and how competent you are to make good decisions. 13 common classes of medications can make you sleepy. Continue reading

Is small cell or non-small cell lung cancer worse?

Generally, small cell lung cancer (SCLC) is worse than non-small cell lung cancer (NSCLC). SCLC accounts for about 10-15% of people who have lung cancer and is the most aggressive form of lung cancer. SCLC usually starts in the breathing tubes (bronchi), and although the cells are small, they grow very quickly and create large tumors. Early on in the course of the disease, there are rarely any symptoms. If caught early (limited-stage disease) 20-25% of people can be potentially cured. Extensive SCLC is more difficult to treat. Continue reading

See also:

Related medical questions

Drug information

Related support groups